메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Triple the Probiotics, Triple the Relief: Life-Space Launches Triple Strength Probiotics in Southeast Asia

Engineered by Australia's leading probiotics expert, this high CFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. SINGAPORE, Nov. 26, 2025 -- Life-Space, Australia's No.1 probiotic brand, proudly unveils Triple Strength Probiotics, a flash charged probiotic designed to deliver intensive gut health support for those with more demanding digestive needs. With 15 premium strains and three times the beneficial bacteria of regular Broad Spectrum Probiotic formulations, this high-strength solution delivering 96 billion CFU's per capsule repr
- 노기식 기자
- 2025-11-26 09:57
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

SINGAPORE, Nov. 26, 2025 -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue® (trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay. Tuznue® is a biosimilar to Herceptin® (trastuzumab), approved for the treatment of breast cancer and metastatic gast
- 김갑성 기자
- 2025-11-26 09:06
Professor Chan Heum Park's Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed "BioCabinet" to Space Aboard Nuri Rocket

SEOUL, South Korea, Nov. 26, 2025 -- Chan Hum Park, M.D., Ph.D., Professor of Otolaryngology at Hallym University Chuncheon Sacred Heart Hospital and Director of the Nano-Bio Regenerative Medical Institute at Hallym University, leads the research team whose space biology payload, BioCabinet, will launch aboard the Nuri rocket's fourth flight on November 27, as part of the mission carrying the Next-Generation Medium Satellite-3. BioCabinet is a research platform with a bio 3D printer and stem cell differentiation incubator. Designed to fabricate artificial heart tissue and evalu
- 김갑성 기자
- 2025-11-26 07:30
알츠하이머 협회, 경구용 세마글루티드 3상 임상시험 결과에 대한 입장 발표

- 이번 임상시험 결과는 다양한 신약 후보 물질에 대한 꾸준한 연구의 필요성을 시사한다 시카고, 2025년 11월 26일 -- 알츠하이머 협회(Alzheimer's Association)가 알츠하이머병 진행 속도를 유의미하게 늦추지 못했다는 evoke 및 evoke+ 임상시험 결과에 아쉬움을 표했다. 해당 연구에서는 초기 알츠하이머병 환자를 대상으로 경구용 세마글루티드 약의 효능을 시험했다. 조안 파이크(Joanne Pike, DrPH) 알츠하이머 협회장은 "비록 바라던 결과는 아니지만, 이번 임상시험 데이터가 알츠하이머병이라는 치명적인 질병을 이해하는 데 도움이 될 것"이라면서 "임상시험 결과와 무관하게, 이번 임상시험 데이터는 알츠하이머병에 대한 이해도를 높이고, 향후 임상 연구의 방향성을 정하는 데 일조할 것이다. 의학계의 연구 환경이 꾸준히 다각화 및 확장되고 있으므로 알츠하이머병 치료와 예방도 여전히 낙관적"이라고 전망했다. 임상시험을 진행했던 제약 회사 노보 노디스크(Novo Nordisk)는 "두 임상시험에서 공통적으로 세마글루티드 치료 후 바이오마
- 김갑성 기자
- 2025-11-26 00:33
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with cancer including the tumor, and multiple components of the tumor microenvironment including endothelial cells, T-cells, and tumor associated macrophages (TAMs) through a common pathway. MT PLEASANT, S.C., Nov. 25, 2025 -- Innova Therapeutics, a biopharmaceutical company, has announced
- 김갑성 기자
- 2025-11-25 23:06
BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan

XI'AN, China, Nov. 25, 2025 -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement is 36 months with a total contract value of US$26 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health
- 김갑성 기자
- 2025-11-25 22:41
Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management Joint research to enhance dementia diagnosis using the brain neurodegeneration imaging software 'Neurophet AQUA' SEOUL, South Korea, Nov. 25, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 25th that it will collaborate with the Florey Institute of Neuroscience and Mental Health (The Florey) in Australia on joint research using its brai
- 김갑성 기자
- 2025-11-25 22:00
Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911

SHANGHAI, Nov. 25, 2025 -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in the Phase I/II clinical trial of its independently developed novel CDH17-targeting antibody-drug conjugate (ADC) (R&D code: 7MW4911) for advanced solid tumors. This Phase I/II clinical trial (CTR20254163) aims to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of 7MW4911 in patients with advanced solid tumors. Previously, 7MW4911 had received IND clearance from F
- 김갑성 기자
- 2025-11-25 22:00
JUNG KWAN JANG Launches Black Friday & Holiday Promotions and Introduces New Wellness Innovations for U.S. Consumers

[ 메디채널 김갑성 기자 ] Global wellness brand JUNG KWAN JANG rolls out major Black Friday and holiday-season promotions across the U.S. New products including EVERYTIME and Hong Sam Won gain momentum on Amazon, Costco, and other major retail channels Korean Red Ginseng rises worldwide as a leading natural, non-GMO, gluten-free health ingredient backed by scientific benefits CERRITOS, Calif., Nov. 25, 2025 -- The world's No.1 ginseng brand, JUNG KWAN JANG, is strengthening its leadership in the U.S. wellness market with nationwide Black Friday and holiday promotions, along with the laun
- 김갑성 기자
- 2025-11-25 21:00
Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations

HONG KONG, Nov. 25, 2025 -- The 2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025) will bring together global leaders to discuss cutting-edge research, innovative medical products, and cross-border collaborations to accelerate progress toward advanced cerebro-cardiovascular care worldwide. Hosted by the InnoHK Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE), the summit will serve as a unique and premium platform uniting leading clinicians, engineers, entrepreneurs, and investors. This year's event features distinguished experts and le
- 김갑성 기자
- 2025-11-25 20:54

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분